Regeneron Strikes Deal with Trump: Free Gene Therapy for Hearing Loss + Lower Drug Prices for Americans
Regeneron will cut U.S. drug prices, offer free gene therapy for hearing loss, and align costs with other countries under a Trump deal.
NOTRELOAD AI
Skillz Wins $420 Million Verdict Against Papaya in Major Bot Fraud Lawsuit
Papaya Gaming must pay Skillz $420 million after a jury found it used bots to cheat players in human-only games.
Grace Therapeutics Gets FDA Feedback on GTx-104: No New Clinical Trials Needed, Resubmission Planned
FDA flagged fixable issues for GTx-104, not rejection. No new trials needed. IV drug may improve brain bleed ICU treatment.
American Airlines Q1 Results: Strong Demand & Revenue Beat, But Jet Fuel Pain Hits Hard
American Airlines hit record $13.9B revenue in Q1 2026 but still lost $382M due to high fuel costs; outlook steady, shares rose.
Activist Investor Pushes Voya to Sell Its $1.1 Trillion Empire
Activist investor pushes Voya to sell itself or weak health unit after losses, despite its $1.1T in assets and flat stock.
OpenAI’s Free ChatGPT for Doctors Triggers Doximity Stock Slide
OpenAI launched ChatGPT for doctors to help with notes and research. It’s free in the US, boosts AI use, and Doximity stock fell.